Work

Association between systemic immune-inflammation index and symptoms of depression and anxiety in patients with type 2 diabetes mellitus

Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder prevalent worldwide, often accompanied by exacerbated symptoms of depression and anxiety, which can affect treatment adherence, glycemic control, and quality of life. AIM To investigate the association between the systemic immune-inflammation index (SII) and depressive and anxiety symptoms, as well as their comorbidity, in patients with T2DM. METHODS A cross-sectional study was conducted using consecutive sampling, enrolling 402 hospitalized patients with T2DM. The SII was calculated as platelet count × neutrophil count/lymphocyte count. Depressive and anxiety symptoms were screened using the validated Chinese versions of the 9-item Patient Health Questionnaire and 7-item Generalized Anxiety Disorder scale, with a score ≥ 5 defined as elevated symptoms. Multivariable logistic regression, subgroup interaction analysis, and restricted cubic spline analysis were performed to estimate independent associations. RESULTS The prevalence of elevated depressive symptoms, elevated anxiety symptoms, and their comorbidity increased significantly with ascending SII tertiles (all P < 0.001). In fully adjusted models, the highest SII tertile was associated with higher odds of elevated depressive symptoms [odds ratio (OR) = 3.93, 95% confidence interval (95%CI): 2.18–7.08, P < 0.001], elevated anxiety symptoms (OR = 9.21, 95%CI: 4.16–20.39, P < 0.001), and their comorbidity (OR = 5.41, 95%CI: 3.21–9.11, P < 0.001) compared with the lowest tertile. Subgroup analysis identified significant interactions between alcohol consumption and the SII on depressive symptoms (P for interaction = 0.010) and between stroke history (P for interaction = 0.018) and BMI (P for interaction = 0.024) and the SII on anxiety symptoms. Restricted cubic spline analysis confirmed a significant nonlinear dose–response relationship between the SII and elevated depressive and anxiety symptoms (all P for nonlinearity < 0.05). CONCLUSION An elevated SII is independently associated with a higher prevalence of elevated depressive symptoms, elevated anxiety symptoms, and their comorbidity in hospitalized patients with T2DM in a nonlinear pattern.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7204520653
FWCI:
Cites: 26
Cited by:
Related to: 10